USE OF ANTI-FCYRI AND/OR ANTI-FCYRIIA ANTIBODIES FOR TREATING ARTHRITIS, INFLAMMATION, THROMBOCYTOPENIA AND ALLERGIC SHOCK

摘要

The present invention relates to the prevention and/or treatment of arthritic, inflammatory and/or allergic reactions as well as thrombocytopenia, by blocking the human receptors FcyRI and FcyRIIA. It is disclosed a mouse monoclonal antibody (mAb) which efficiently blocks human FcyRI and can therefore be used, alone or in a combination product, for example with an anti-hFcyRIIA blocking antibody, in the prevention and/or the treatment of these diseases.